Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Cytosorbents Corporation (CTSO) had Return on Tangible Equity of -10.17% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$8.73M |
|
$-1.48M |
|
$2.52M |
|
$6.21M |
|
$12.61M |
|
$-3.89M |
|
$2.41M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-1.48M |
|
$-3.89M |
|
$-3.29M |
|
60.73M |
|
60.73M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$25.41M |
|
$8.72M |
|
$25.37M |
|
$50.78M |
|
$9.74M |
|
$14.19M |
|
$26.50M |
|
$36.24M |
|
$14.54M |
|
$14.54M |
|
$14.54M |
|
62.53M |
|
| Cash Flow Statement Financials | |
$-3.46M |
|
$-0.05M |
|
$6.83M |
|
$9.76M |
|
$13.11M |
|
$3.35M |
|
$0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.61 |
|
-- |
|
-- |
|
0.49 |
|
0.98 |
|
71.13% |
|
-44.54% |
|
-44.54% |
|
-- |
|
-16.94% |
|
-16.94% |
|
$-3.47M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.83 |
|
1.14 |
|
79.10 |
|
-10.17% |
|
|
Return on Tangible Equity |
-10.17% |
-2.91% |
|
-5.15% |
|
$0.23 |
|
$-0.06 |
|
$-0.06 |
|